3 results
Approved WMOSuspended
In an effort to collect safety and effectiveness information on the stent, Medlogics is conducting the Cobra II study.
Approved WMOCompleted
To assess uptake of 11C-osimertinib in tumor lesions of T790M double positive patients and T790M double negative patients, thereby evaluating specific and aspecific (off-target) 11C-osimertinib accumulation in tumor tissue.
Approved WMOCompleted
To determine sensitivity, specificity, positive predictive value and negative predictive value of the spectroscopic cervical imaging device in detection of high grade cervical intraepithelial neoplasia.